Europe Oncology Biosimilars Market Report 2016

Publisher Name :
Date: 21-Sep-2016
No. of pages: 123

Notes:

Sales, means the sales volume of Oncology Biosimilars

Revenue, means the sales value of Oncology Biosimilars

This report studies sales (consumption) of Oncology Biosimilars in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Covidien llc (Medtronic)

- Johnson & Johnson MEDICAL

- Bolton Surgical

- Platts & Nisbett

- Frankenman International

- Changzhou Waston

- Jiangsu Qianjing Medical

- Changzhou Anker Medical

- Changzhou Tongchuang Medical

- Jiangsu Reable Medical

- Changzhou Resource Medical

- Jiangsu Kangjin Medical

- Pfizer

- Wockhardt

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Oncology Biosimilars in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on sales, market share and growth rate of Oncology Biosimilars in each application, can be divided into

- Application 1

- Application 2

- Application 3

Europe Oncology Biosimilars Market Report 2016

Table of Contents
Europe Oncology Biosimilars Market Report 2016
1 Oncology Biosimilars Overview
1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Oncology Biosimilars
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Oncology Biosimilars Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Oncology Biosimilars (2011-2021)
1.5.1 Europe Oncology Biosimilars Sales and Growth Rate (2011-2021)
1.5.2 Europe Oncology Biosimilars Revenue and Growth Rate (2011-2021)
2 Europe Oncology Biosimilars by Manufacturers, Type and Application
2.1 Europe Oncology Biosimilars Market Competition by Manufacturers
2.1.1 Europe Oncology Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Oncology Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Oncology Biosimilars (Volume and Value) by Type
2.2.1 Europe Oncology Biosimilars Sales and Market Share by Type (2011-2016)
2.2.2 Europe Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
2.3 Europe Oncology Biosimilars (Volume and Value) by Countries
2.3.1 Europe Oncology Biosimilars Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Oncology Biosimilars Revenue and Market Share by Countries (2011-2016)
2.4 Europe Oncology Biosimilars (Volume) by Application
3 Germany Oncology Biosimilars (Volume, Value and Sales Price)
3.1 Germany Oncology Biosimilars Sales and Value (2011-2016)
3.1.1 Germany Oncology Biosimilars Sales and Growth Rate (2011-2016)
3.1.2 Germany Oncology Biosimilars Revenue and Growth Rate (2011-2016)
3.1.3 Germany Oncology Biosimilars Sales Price Trend (2011-2016)
3.2 Germany Oncology Biosimilars Sales and Market Share by Manufacturers
3.3 Germany Oncology Biosimilars Sales and Market Share by Type
3.4 Germany Oncology Biosimilars Sales and Market Share by Application
4 France Oncology Biosimilars (Volume, Value and Sales Price)
4.1 France Oncology Biosimilars Sales and Value (2011-2016)
4.1.1 France Oncology Biosimilars Sales and Growth Rate (2011-2016)
4.1.2 France Oncology Biosimilars Revenue and Growth Rate (2011-2016)
4.1.4 France Oncology Biosimilars Sales Price Trend (2011-2016)
4.2 France Oncology Biosimilars Sales and Market Share by Manufacturers
4.3 France Oncology Biosimilars Sales and Market Share by Type
4.4 France Oncology Biosimilars Sales and Market Share by Application
5 UK Oncology Biosimilars (Volume, Value and Sales Price)
5.1 UK Oncology Biosimilars Sales and Value (2011-2016)
5.1.1 UK Oncology Biosimilars Sales and Growth Rate (2011-2016)
5.1.2 UK Oncology Biosimilars Revenue and Growth Rate (2011-2016)
5.1.5 UK Oncology Biosimilars Sales Price Trend (2011-2016)
5.2 UK Oncology Biosimilars Sales and Market Share by Manufacturers
5.3 UK Oncology Biosimilars Sales and Market Share by Type
5.4 UK Oncology Biosimilars Sales and Market Share by Application
6 Russia Oncology Biosimilars (Volume, Value and Sales Price)
6.1 Russia Oncology Biosimilars Sales and Value (2011-2016)
6.1.1 Russia Oncology Biosimilars Sales and Growth Rate (2011-2016)
6.1.2 Russia Oncology Biosimilars Revenue and Growth Rate (2011-2016)
6.1.6 Russia Oncology Biosimilars Sales Price Trend (2011-2016)
6.2 Russia Oncology Biosimilars Sales and Market Share by Manufacturers
6.3 Russia Oncology Biosimilars Sales and Market Share by Type
6.4 Russia Oncology Biosimilars Sales and Market Share by Application
7 Italy Oncology Biosimilars (Volume, Value and Sales Price)
7.1 Italy Oncology Biosimilars Sales and Value (2011-2016)
7.1.1 Italy Oncology Biosimilars Sales and Growth Rate (2011-2016)
7.1.2 Italy Oncology Biosimilars Revenue and Growth Rate (2011-2016)
7.1.7 Italy Oncology Biosimilars Sales Price Trend (2011-2016)
7.2 Italy Oncology Biosimilars Sales and Market Share by Manufacturers
7.3 Italy Oncology Biosimilars Sales and Market Share by Type
7.4 Italy Oncology Biosimilars Sales and Market Share by Application
8 Spain Oncology Biosimilars (Volume, Value and Sales Price)
8.1 Spain Oncology Biosimilars Sales and Value (2011-2016)
8.1.1 Spain Oncology Biosimilars Sales and Growth Rate (2011-2016)
8.1.2 Spain Oncology Biosimilars Revenue and Growth Rate (2011-2016)
8.1.8 Spain Oncology Biosimilars Sales Price Trend (2011-2016)
8.2 Spain Oncology Biosimilars Sales and Market Share by Manufacturers
8.3 Spain Oncology Biosimilars Sales and Market Share by Type
8.4 Spain Oncology Biosimilars Sales and Market Share by Application
9 Benelux Oncology Biosimilars (Volume, Value and Sales Price)
9.1 Benelux Oncology Biosimilars Sales and Value (2011-2016)
9.1.1 Benelux Oncology Biosimilars Sales and Growth Rate (2011-2016)
9.1.2 Benelux Oncology Biosimilars Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Oncology Biosimilars Sales Price Trend (2011-2016)
9.2 Benelux Oncology Biosimilars Sales and Market Share by Manufacturers
9.3 Benelux Oncology Biosimilars Sales and Market Share by Type
9.4 Benelux Oncology Biosimilars Sales and Market Share by Application
10 Europe Oncology Biosimilars Manufacturers Analysis
10.1 Covidien llc (Medtronic)
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Oncology Biosimilars Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Covidien llc (Medtronic) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Johnson & Johnson MEDICAL
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Oncology Biosimilars Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Johnson & Johnson MEDICAL Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Bolton Surgical
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Oncology Biosimilars Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Bolton Surgical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Platts & Nisbett
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Oncology Biosimilars Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Platts & Nisbett Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Frankenman International
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Oncology Biosimilars Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Frankenman International Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Changzhou Waston
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Oncology Biosimilars Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Changzhou Waston Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Jiangsu Qianjing Medical
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Oncology Biosimilars Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Jiangsu Qianjing Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Changzhou Anker Medical
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Oncology Biosimilars Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Changzhou Anker Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Changzhou Tongchuang Medical
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Oncology Biosimilars Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Changzhou Tongchuang Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Jiangsu Reable Medical
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Oncology Biosimilars Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Jiangsu Reable Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 Changzhou Resource Medical
10.12 Jiangsu Kangjin Medical
10.13 Pfizer
10.14 Wockhardt
11 Oncology Biosimilars Manufacturing Cost Analysis
11.1 Oncology Biosimilars Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Oncology Biosimilars
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Oncology Biosimilars Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Oncology Biosimilars Market Forecast (2016-2021)
14.1 Germany Oncology Biosimilars Sales Forecast (2016-2021)
14.2 France Oncology Biosimilars Sales Forecast (2016-2021)
14.3 UK Oncology Biosimilars Sales Forecast (2016-2021)
14.4 Russia Oncology Biosimilars Sales Forecast (2016-2021)
14.5 Italy Oncology Biosimilars Sales Forecast (2016-2021)
14.6 Spain Oncology Biosimilars Sales Forecast (2016-2021)
14.7 Benelux Oncology Biosimilars Sales Forecast (2016-2021)
14.8 Europe Oncology Biosimilars Sales Forecast by Type (2016-2021)
14.9 Europe Oncology Biosimilars Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Oncology Biosimilars
Table Classification of Oncology Biosimilars
Figure Europe Sales Market Share of Oncology Biosimilars by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Oncology Biosimilars
Figure Europe Sales Market Share of Oncology Biosimilars by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure France Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure UK Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Russia Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Italy Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Spain Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Benelux Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Europe Oncology Biosimilars Sales and Growth Rate (2011-2021)
Figure Europe Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Table Europe Oncology Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table Europe Oncology Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Oncology Biosimilars Sales Share by Manufacturers
Figure 2016 Oncology Biosimilars Sales Share by Manufacturers
Table Europe Oncology Biosimilars Revenue by Manufacturers (2015 and 2016)
Table Europe Oncology Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 Europe Oncology Biosimilars Revenue Share by Manufacturers
Table Europe Oncology Biosimilars Sales and Market Share by Type (2011-2016)
Table Europe Oncology Biosimilars Sales Share by Type (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Type (2011-2016)
Figure Europe Oncology Biosimilars Sales Growth Rate by Type (2011-2016)
Table Europe Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
Table Europe Oncology Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Oncology Biosimilars by Type (2011-2016)
Figure Europe Oncology Biosimilars Revenue Growth Rate by Type (2011-2016)
Table Europe Oncology Biosimilars Sales and Market Share by Countries (2011-2016)
Table Europe Oncology Biosimilars Sales Share by Countries (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Countries (2011-2016)
Table Europe Oncology Biosimilars Revenue and Market Share by Countries (2011-2016)
Table Europe Oncology Biosimilars Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Oncology Biosimilars by Countries (2011-2016)
Table Europe Oncology Biosimilars Sales and Market Share by Application (2011-2016)
Table Europe Oncology Biosimilars Sales Share by Application (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Application (2011-2016)
Figure Germany Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Germany Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Germany Oncology Biosimilars Sales Price Trend (2011-2016)
Table Germany Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Germany Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Germany Oncology Biosimilars Sales by Type (2015 and 2016)
Table Germany Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Germany Oncology Biosimilars Sales by Application (2015 and 2016)
Table Germany Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure France Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure France Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure France Oncology Biosimilars Sales Price Trend (2011-2016)
Table France Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table France Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table France Oncology Biosimilars Sales by Type (2015 and 2016)
Table France Oncology Biosimilars Market Share by Type (2015 and 2016)
Table France Oncology Biosimilars Sales by Application (2015 and 2016)
Table France Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure UK Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure UK Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure UK Oncology Biosimilars Sales Price Trend (2011-2016)
Table UK Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table UK Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table UK Oncology Biosimilars Sales by Type (2015 and 2016)
Table UK Oncology Biosimilars Market Share by Type (2015 and 2016)
Table UK Oncology Biosimilars Sales by Application (2015 and 2016)
Table UK Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Russia Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Russia Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Russia Oncology Biosimilars Sales Price Trend (2011-2016)
Table Russia Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Russia Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Russia Oncology Biosimilars Sales by Type (2015 and 2016)
Table Russia Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Russia Oncology Biosimilars Sales by Application (2015 and 2016)
Table Russia Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Italy Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Italy Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Italy Oncology Biosimilars Sales Price Trend (2011-2016)
Table Italy Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Italy Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Italy Oncology Biosimilars Sales by Type (2015 and 2016)
Table Italy Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Italy Oncology Biosimilars Sales by Application (2015 and 2016)
Table Italy Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Spain Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Spain Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Spain Oncology Biosimilars Sales Price Trend (2011-2016)
Table Spain Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Spain Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Spain Oncology Biosimilars Sales by Type (2015 and 2016)
Table Spain Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Spain Oncology Biosimilars Sales by Application (2015 and 2016)
Table Spain Oncology Biosimilars Market Share by Application (2015 and 2016)
Figure Benelux Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Benelux Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Benelux Oncology Biosimilars Sales Price Trend (2011-2016)
Table Benelux Oncology Biosimilars Sales by Manufacturers (2015 and 2016)
Table Benelux Oncology Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Benelux Oncology Biosimilars Sales by Type (2015 and 2016)
Table Benelux Oncology Biosimilars Market Share by Type (2015 and 2016)
Table Benelux Oncology Biosimilars Sales by Application (2015 and 2016)
Table Benelux Oncology Biosimilars Market Share by Application (2015 and 2016)
Table Oncology Biosimilars Basic Information List
Table Covidien llc (Medtronic) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Covidien llc (Medtronic) Oncology Biosimilars Sales Market Share (2011-2016)
Table Johnson & Johnson MEDICAL Basic Information List
Table Johnson & Johnson MEDICAL Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson MEDICAL Oncology Biosimilars Sales Market Share (2011-2016)
Table Bolton Surgical Basic Information List
Table Bolton Surgical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bolton Surgical Oncology Biosimilars Sales Market Share (2011-2016)
Table Platts & Nisbett Basic Information List
Table Platts & Nisbett Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Platts & Nisbett Oncology Biosimilars Sales Market Share (2011-2016)
Table Frankenman International Basic Information List
Table Frankenman International Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Frankenman International Oncology Biosimilars Sales Market Share (2011-2016)
Table Changzhou Waston Basic Information List
Table Changzhou Waston Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Waston Oncology Biosimilars Sales Market Share (2011-2016)
Table Jiangsu Qianjing Medical Basic Information List
Table Jiangsu Qianjing Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Qianjing Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Changzhou Anker Medical Basic Information List
Table Changzhou Anker Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Anker Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Changzhou Tongchuang Medical Basic Information List
Table Changzhou Tongchuang Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Tongchuang Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Jiangsu Reable Medical Basic Information List
Table Jiangsu Reable Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Reable Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Changzhou Resource Medical Basic Information List
Table Changzhou Resource Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Resource Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Jiangsu Kangjin Medical Basic Information List
Table Jiangsu Kangjin Medical Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Kangjin Medical Oncology Biosimilars Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Oncology Biosimilars Sales Market Share (2011-2016)
Table Wockhardt Basic Information List
Table Wockhardt Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wockhardt Oncology Biosimilars Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure Germany Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Germany Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure France Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure France Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure UK Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure UK Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Russia Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Italy Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Spain Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table Europe Oncology Biosimilars Sales Forecast by Type (2016-2021)
Table Europe Oncology Biosimilars Sales Forecast by Application (2016-2021)
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • United States Glucosamine Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 124
    Notes: Sales, means the sales volume of Glucosamine Revenue, means the sales value of Glucosamine This report studies sales (consumption) of Glucosamine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - CELLMARK - Cargill - AMPIL - Koyo Chemical - Pharma Base - MAHTANI CHITOSAN - Panvo Organics - Bio-gen Extracts - Wanbury -......
  • United States Ampicillin Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 98
    Notes: Sales, means the sales volume of Ampicillin Revenue, means the sales value of Ampicillin This report studies sales (consumption) of Ampicillin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - DSM - ACS Dobfar - Kopran - Antibioticos - United Laboratories - Shandong Lukang Pharmaceutical - CSPC Pharmaceutical - North China Pharmace......
  • United States Letrozole Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 97
    Notes: Sales, means the sales volume of Letrozole Revenue, means the sales value of Letrozole This report studies sales (consumption) of Letrozole in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Teva - Actavis - Mylan - Fresenius Kabi - Endo - Apotex - Sun Pharma - Hengrui Market Segment by States, covering - Calif......
  • United States Nonsteroidal Anti-inflammatory Drug Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Nonsteroidal Anti-inflammatory Drug Revenue, means the sales value of Nonsteroidal Anti-inflammatory Drug This report studies sales (consumption) of Nonsteroidal Anti-inflammatory Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bayer - Actavis - Teva - Mylan - Pfizer - Novartis - Horizon Pharma......
  • United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 107
    Notes: Sales, means the sales volume of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, means the sales value of Non-alcoholic Fatty Liver Disease (NAFLD) Drug This report studies sales (consumption) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Conatus Pharmaceuticals - Daewoong Pharmaceutical - Galmed Internat......
  • United States Tumor Marker Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 96
    Notes: Sales, means the sales volume of Tumor Marker Revenue, means the sales value of Tumor Marker This report studies sales (consumption) of Tumor Marker in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Abbott - Siemens - Alere - Johnson - BD - Nova - ... Market Segment by States, covering - California - Texas......
  • United States Mildronate Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Mildronate Revenue, means the sales value of Mildronate This report studies sales (consumption) of Mildronate in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Psypharm - Latvian company - Jinan Chenghui-shuangda Chemical - Canadian Pharmacy - Grindex company - Slovakia - United Pharmacies - chemBli......
  • United States Argatroban Powder Market Report 2017
    Published: 22-Feb-2017        Price: US 3800 Onwards        Pages: 116
    Notes: Sales, means the sales volume of Argatroban Powder Revenue, means the sales value of Argatroban Powder This report studies sales (consumption) of Argatroban Powder in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Pfizer, Inc - SANDOZ - GlaxoSmithKline Plc - fresenius-kabi - Eagle Pharmaceuticals, Inc - Mitsubishi Tanabe Pharma - Teva Ph......
  • Global Nonalcoholic Steatohepatitis (NASH) Sales Market Report 2017
    Published: 22-Feb-2017        Price: US 4000 Onwards        Pages: 118
    Notes: Sales, means the sales volume of Nonalcoholic Steatohepatitis (NASH) Revenue, means the sales value of Nonalcoholic Steatohepatitis (NASH) This report studies sales (consumption) of Nonalcoholic Steatohepatitis (NASH) in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Boehringer Ingelheim?......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs